Drug makers seek more tax exemptions for R&D spending
Published: 2008-01-10 06:58:00
Updated: 2008-01-10 06:58:00
The Korea Pharmaceutical Manufacturers Association (KPMA) will seek to expand tax exemptions for corporate investment in research and development (R&D) as part of efforts to stimulate pharmaceutical companies' R&D spending in the era of free trade agreements (FTAs).
Currently, pharmaceutical c...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
